Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS EP News Bureau Nov 16, 2020 The gross proceeds of the deal are €12 million
Bone Therapeutics commences research on combined cell-matrix products EP News Bureau Jan 6, 2015 €1 million funding secured from the Walloon Region to investigate these innovative products for the treatment of large bone…
